The contribution will allow UArizona researchers to continue developing better, more efficient and effective tests for people across the state.
The University of Arizona has licensed new radio-labeling chemistry for PET contrast agents to startup TheraCea Pharma.
In pre-clinical studies, researchers found that low-dose ketamine infusions can improve pain, depression and levodopa-induced dyskinesia in Parkinson's patients.
Give yourself the gift of good health! The University of Arizona Health Sciences is offering an uplifting program to improve health and reduce stress.
Researchers in the College of Pharmacy say compounds targeting proteins involved in viral replication may further drug development for treating COVID-19.
University of Arizona Department of Urology faculty member Dr. Sunchin Kim and general urology nurse practitioner Cara Whittingham will provide patient care at the Cortaro Road Banner clinic in Tucson.
Dr. Donna D. Zhang’s research focuses on developing pharmaceuticals to prevent or treat exposure to arsenic, which has affected more than 160 million people worldwide.
The tele-ultrasound training program for lung point-of-care ultrasound (POCUS) will enable rural emergency departments to more effectively identify and treat suspected COVID-19 patients.
Two faculty members inducted to National Academy of Inventors, ‘Gut Group’ team wins $250,000 for gastrointestinal cancer research, Dr. Chalasani wins NCI team leadership award, and new physicians join as pediatrics, infectious disease specialists.
The Arizona portion of an 11-state effort, funded by a $12 million federal award, to address the uneven impact of the pandemic on racial and ethnic minority communities will be led by the UArizona Health Sciences.